Thymosin β4 limits inflammation through autophagy

References

• Goldstein AL. Slater FD and White A. Preparation, assay, and partial purification of a thymic lymphocytopoietic factor (thymosin). Proc Natl Acad Sci U S A. 1966;56:1010–1017.
   PubMed Web of Science ®Google Scholar
• Ballweber E, Hannappel E, Huff T, et al. Polymerisation of chemically cross-linked actin: thymosinbeta(4) complex to filamentous actin: alteration in helical parameters and visualisation of thymosin beta(4) binding on F-actin. J Mol Biol. 2002;315:613–625.
   PubMed Web of Science ®Google Scholar
• Safer D, Elzinga M, Nachmias VT. Thymosin beta 4 and Fx, an actin-sequestering peptide, are indistinguishable. J Biol Chem. 1991;266:4029–4032.
   PubMed Web of Science ®Google Scholar
• Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med. 2005;11:421–429.
   PubMed Web of Science ®Google Scholar
• Malinda KM, Goldstein AL, Kleinman HK. Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells. Faseb J. 1997;11:474–481.
   PubMed Web of Science ®Google Scholar
• Evans MA, Smart N, Dubé KN, et al. Thymosin beta4-sulfoxide attenuates inflammatory cell infiltration and promotes cardiac wound healing. Nat Commun. 2013;4:2081.
   PubMed Web of Science ®Google Scholar
• Sosne G, Qiu P, Christopherson PL, et al. Thymosin beta 4 suppression of corneal NFkappaB: a potential anti-inflammatory pathway. Exp Eye Res. 2007;84:663–669.
   PubMed Web of Science ®Google Scholar
• Kumar S, Gupta S. Thymosin beta 4 prevents oxidative stress by targeting antioxidant and anti-apoptotic genes in cardiac fibroblasts. PLoS One. 2011;6:e26912.
   PubMed Web of Science ®Google Scholar
• Wei C, Kumar S, Kim IK, et al. Thymosin beta 4 protects cardiomyocytes from oxidative stress by targeting anti-oxidative enzymes and anti-apoptotic genes. PLoS One. 2012;7:e42586.
   PubMed Web of Science ®Google Scholar
• Philp D, Goldstein AL, Kleinman HK. Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development. Mech Ageing Dev. 2004;125:113–115.
   PubMed Web of Science ®Google Scholar
• Ehrlich HP, Hazard SW 3rd. Thymosin beta4 enhances repair by organizing connective tissue and preventing the appearance of myofibroblasts. Ann N Y Acad Sci. 2010;1194:118–124.
   PubMed Web of Science ®Google Scholar
• Cha HJ, Jeong MJ, Kleinman HK. Role of thymosin beta4 in tumor metastasis and angiogenesis. J Natl Cancer Inst. 2003;95:1674–1680.
   PubMed Web of Science ®Google Scholar
• Huang HC, Hu CH, Tang MC, et al. Thymosin beta4 triggers an epithelial-mesenchymal transition in colorectal carcinoma by upregulating integrin-linked kinase. Oncogene. 2007;26:2781–2790.
   PubMed Web of Science ®Google Scholar
• Wang WS, Chen PM, Hsiao HL, et al. Overexpression of the thymosin beta-4 gene is associated with increased invasion of SW480 colon carcinoma cells and the distant metastasis of human colorectal carcinoma. Oncogene. 2004;23:6666–6671.
   PubMed Web of Science ®Google Scholar
• Sosne G, Rimmer D, Kleinman HK, et al. Thymosin beta 4: a potential novel therapy for neurotrophic keratopathy, dry eye, and ocular surface diseases. Vitam Horm. 2016;102:277–306.
   PubMed Web of Science ®Google Scholar
• Sosne G, Christopherson PL, Barrett RP, et al. Thymosin-beta4 modulates corneal matrix metalloproteinase levels and polymorphonuclear cell infiltration after alkali injury. Invest Ophthalmol Vis Sci. 2005;46:2388–2395.
   PubMed Web of Science ®Google Scholar
• Young JD, Lawrence AJ, MacLean AG, et al. Thymosin beta 4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoids. Nat Med. 1999;5:1424–1427.
   PubMed Web of Science ®Google Scholar
• Badamchian M, Fagarasan MO, Danner RL, et al. Thymosin beta(4) reduces lethality and down-regulates inflammatory mediators in endotoxin-induced septic shock. Int Immunopharmacol. 2003;3:1225–1233.
   PubMed Web of Science ®Google Scholar
• Goldstein AL, Kleinman HK. Advances in the basic and clinical applications of thymosin beta4. Expert Opin Biol Ther. 2015;15(Suppl 1):S139–45.
   PubMedGoogle Scholar
• Liu T, Zhang L, Joo D, et al. NF-kappaB signaling in inflammation. Signal Transduct Target Ther. 2017;2.
   Google Scholar
• Qiu P, Wheater MK, Qiu Y, et al. Thymosin beta4 inhibits TNF-alpha-induced NF-kappaB activation, IL-8 expression, and the sensitizing effects by its partners PINCH-1 and ILK. Faseb J. 2011;25:1815–1826.
   PubMed Web of Science ®Google Scholar
• Marks ED, Kumar A. Thymosin beta4: roles in development, repair, and engineering of the cardiovascular system. Vitam Horm. 2016;102:227–249.
   PubMed Web of Science ®Google Scholar
• Bock-Marquette I, Saxena A, White MD, et al. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature. 2004;432:466–472.
   PubMed Web of Science ®Google Scholar
• Mutchnick MG, Lee HH, Hollander DI, et al. Defective in vitro gamma interferon production and elevated serum immunoreactive thymosin beta 4 levels in patients with inflammatory bowel disease. Clin Immunol Immunopathol. 1988;47:84–92.
   PubMedGoogle Scholar
• Zheng XY, Lv YF, Li S, et al. Recombinant adeno-associated virus carrying thymosin beta4 suppresses experimental colitis in mice. World J Gastroenterol. 2017;23:242–255.
   PubMed Web of Science ®Google Scholar
• Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature. 2011;469:323–335.
   PubMed Web of Science ®Google Scholar
• Sumpter R Jr, Levine B. Autophagy and innate immunity: triggering, targeting and tuning. Semin Cell Dev Biol. 2010;21:699–711.
   PubMed Web of Science ®Google Scholar
• Saitoh T, Akira S. Regulation of inflammasomes by autophagy. J Allergy Clin Immunol. 2016;138:28–36.
   PubMed Web of Science ®Google Scholar
• Takahama M, Akira S, Saitoh T. Autophagy limits activation of the inflammasomes. Immunol Rev. 2018;281:62–73.
   PubMed Web of Science ®Google Scholar
• Harris J, Hartman M, Roche C, et al. Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation. J Biol Chem. 2011;286:9587–9597.
   PubMed Web of Science ®Google Scholar
• Shi CS, Shenderov K, Huang NN, et al. Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol. 2012;13:255–263.
   PubMed Web of Science ®Google Scholar
• Sprenkeler EG, Gresnigt MS, van de Veerdonk FL. LC3-associated phagocytosis: a crucial mechanism for antifungal host defence against Aspergillus fumigatus. Cell Microbiol. 2016;18:1208–1216.
   PubMed Web of Science ®Google Scholar
• Oikonomou V, Moretti S, Renga G, et al. Noncanonical fungal autophagy inhibits inflammation in response to IFN-gamma via DAPK1. Cell Host Microbe. 2016;20:744–757.
   PubMed Web of Science ®Google Scholar
• Gade P, Ramachandran G, Maachani UB, et al. An IFN-gamma-stimulated ATF6-C/EBP-beta-signaling pathway critical for the expression of death associated protein kinase 1 and induction of autophagy. Proc Natl Acad Sci U S A. 2012;109:10316–10321.
   PubMed Web of Science ®Google Scholar
• Nair S, Hagberg H, Krishnamurthy R, et al. Death associated protein kinases: molecular structure and brain injury. Int J Mol Sci. 2013;14:13858–13872.
   PubMed Web of Science ®Google Scholar
• Nakav S, Cohen S, Feigelson SW, et al. Tumor suppressor death-associated protein kinase attenuates inflammatory responses in the lung. Am J Respir Cell Mol Biol. 2012;46:313–322.
   PubMed Web of Science ®Google Scholar
• Martinez J, Malireddi RK, Lu Q, et al. Molecular characterization of LC3-associated phagocytosis reveals distinct roles for Rubicon, NOX2 and autophagy proteins. Nat Cell Biol. 2015;17:893–906.
   PubMed Web of Science ®Google Scholar
• Piludu M, Piras M, Pichiri G, et al. Thymosin beta 4 may translocate from the cytoplasm in to the nucleus in HepG2 cells following serum starvation. An Ultrastructural Study. PLoS One. 2015;10:e0119642.
   PubMed Web of Science ®Google Scholar
• Aguilera MO, Berón W, Colombo MI. The actin cytoskeleton participates in the early events of autophagosome formation upon starvation induced autophagy. Autophagy. 2012;8:1590–1603.
   PubMed Web of Science ®Google Scholar
• de Luca A, Smeekens SP, Casagrande A, et al. IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans. Proc Natl Acad Sci U S A. 2014;111:3526–3531.
   PubMed Web of Science ®Google Scholar
• Akoumianaki T, Kyrmizi I, Valsecchi I, et al. Aspergillus cell wall melanin blocks LC3-associated phagocytosis to promote pathogenicity. Cell Host Microbe. 2016;19:79–90.
   PubMed Web of Science ®Google Scholar
• Kyrmizi I, Gresnigt MS, Akoumianaki T, et al. Corticosteroids block autophagy protein recruitment in Aspergillus fumigatus phagosomes via targeting dectin-1/Syk kinase signaling. J Immunol. 2013;191:1287–1299.
   PubMed Web of Science ®Google Scholar
• Chiriaco M, Salfa I, Di Matteo G, et al. Chronic granulomatous disease: clinical, molecular, and therapeutic aspects. Pediatr Allergy Immunol. 2016;27:242–253.
   PubMed Web of Science ®Google Scholar
• Sm H. Chronic granulomatous disease. Hematol Oncol Clin North Am. 2013;27:89–99, viii.
   PubMed Web of Science ®Google Scholar
• Zhong Z, Sanchez-Lopez E, Karin M. Autophagy, inflammation, and immunity: a troika governing cancer and its treatment. Cell. 2016;166:288–298.
   PubMed Web of Science ®Google Scholar
• Shaw SY, Tran K, Castoreno AB, et al. Selective modulation of autophagy, innate immunity, and adaptive immunity by small molecules. ACS Chem Biol. 2013;8:2724–2733.
   PubMed Web of Science ®Google Scholar
• Lv XX, Liu SS, Hu ZW. Autophagy-inducing natural compounds: a treasure resource for developing therapeutics against tissue fibrosis. J Asian Nat Prod Res. 2017;19:101–108.
   PubMed Web of Science ®Google Scholar
• Levine B, Packer M, Codogno P. Development of autophagy inducers in clinical medicine. J Clin Invest. 2015;125:14–24.
   PubMed Web of Science ®Google Scholar
• Kroemer G. Autophagy: a druggable process that is deregulated in aging and human disease. J Clin Invest. 2015;125:1–4.
   PubMed Web of Science ®Google Scholar